Why Hidden Fees Matter When Choosing Wegovy or Mounjaro
Wegovy vs Mounjaro: Complete Price Transparency Comparison
Many patients researching Wegovy versus Mounjaro discover attractive headline prices, only to face unexpected consultation fees, prescription charges, and administration costs at checkout. EverydayMeds eliminates this pricing anxiety through radical transparency - our published prices include every element of your treatment journey. Whether you choose Wegovy (semaglutide) or Mounjaro (tirzepatide), you'll pay exactly what's displayed: clinical assessment, prescriber review, prescription processing, medication supply, and temperature-controlled delivery.
This approach matters because weight management medications require ongoing monthly purchases, making hidden fees particularly costly over time. Competitors often advertise £60 medication prices, then add £35 consultation fees and £15 prescription charges, creating a true cost of £110 per order. Our transparent Wegovy and Mounjaro pricing eliminates these surprise charges, allowing accurate treatment budgeting from day one.
Comprehensive Wegovy and Mounjaro Pricing Structure
EverydayMeds offers both Wegovy and Mounjaro through identical pricing frameworks, starting with single pens at £79.99 for starter doses. Our Wegovy range includes 0.25mg (£79.99), 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), and 2.4mg maintenance dose (£209.99). Multi-pen bundles provide treatment continuity, such as the Intro Duo combining 0.25mg and 0.5mg pens for £169.99, covering your first eight weeks of dose escalation.
New customers apply discount code FIRST40 at checkout to access these published prices, whilst returning customers use code DOSE25. These aren't additional discounts - they're part of our transparent pricing system ensuring you pay exactly what's advertised. Bundle options like the Progress Trio (0.5mg, 1mg, 1.7mg pens) cost £369.99, providing three months of structured dose increases without multiple ordering requirements.
Clinical Evidence Supporting Wegovy and Mounjaro Selection
Both Wegovy and Mounjaro demonstrated significant efficacy in their respective clinical trials, though direct head-to-head comparisons aren't available due to different study designs. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved an average of approximately clinically studied weight loss at 68 weeks (Wilding et al., NEJM, 2021). The STEP programme included over 4,500 participants across multiple studies, establishing Wegovy's cardiovascular safety profile.
Mounjaro's SURMOUNT trials showed similar effectiveness in weight management applications, with patients experiencing substantial weight reductions when combined with lifestyle modifications. Both medications require prescription-only access following comprehensive clinical assessment, as individual patient factors influence treatment selection more than trial statistics alone.
How Wegovy and Mounjaro Work: Mechanism Differences
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone to reduce appetite and promote satiety after smaller meals. This single-pathway approach targets the brain's appetite control centres, potentially reducing food cravings and supporting portion control. Mounjaro utilises tirzepatide, a dual GIP and GLP-1 receptor agonist, engaging two complementary pathways for appetite regulation. Both medications work by slowing gastric emptying, meaning food stays in your stomach longer, creating sustained fullness between meals. Your prescriber will consider your medical history, current medications, and treatment goals when recommending either Wegovy's focused GLP-1 approach or Mounjaro's dual-receptor mechanism.
Streamlined Wegovy and Mounjaro Ordering Process
EverydayMeds provides identical ordering experiences for both Wegovy and Mounjaro, beginning with a comprehensive 3-minute clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review every application within 3 working days (or 24 hours with express service), determining medication suitability and appropriate starting doses. Once approved, your chosen medication ships via next-day delivery using specialised cold-chain packaging to maintain temperature integrity during transport. The entire process from assessment to delivery typically completes within 4-5 working days, with tracking provided throughout. Payment processing occurs only after prescriber approval, ensuring you're never charged for medications that aren't clinically appropriate for your circumstances.
Storage and Practical Considerations: Wegovy vs Mounjaro
Both Wegovy and Mounjaro require refrigerated storage at 2-8°C before first use, though Wegovy offers superior travel flexibility with 6 weeks of room temperature stability (below 30°C) compared to Mounjaro's 21-day limit. Each medication uses pre-filled FlexTouch pen injectors for once-weekly subcutaneous administration, rotating between thigh, abdomen, or upper arm injection sites. Dose escalation protocols differ slightly between treatments, with Wegovy following a structured 4-week progression through 0.25mg, 0.5mg, 1mg, 1.7mg, before reaching 2.4mg maintenance dosing. Both medications work alongside reduced-calorie diet and increased physical activity, requiring long-term commitment for sustained weight management benefits. Your prescriber will provide detailed injection technique guidance and escalation schedules specific to your chosen treatment pathway.
Why Transparent Pricing Matters for Wegovy and Mounjaro Treatment
Weight management with Wegovy or Mounjaro typically requires 6-12 months of continuous treatment, making pricing transparency crucial for treatment adherence and financial planning. Hidden consultation fees can add £420-840 annually to your treatment costs, potentially forcing difficult choices between medication continuity and budget constraints. EverydayMeds' transparent approach means your monthly medication budget remains predictable, supporting consistent treatment without financial surprises.
This pricing clarity becomes particularly valuable during dose escalation phases, where you'll progress through multiple pen strengths over 16+ weeks. Knowing your exact costs upfront allows proper treatment planning, reducing the risk of treatment interruption due to unexpected charges that commonly derail weight management progress.
Getting Started with Wegovy or Mounjaro Through EverydayMeds
Begin your transparent pricing journey by selecting either Wegovy or Mounjaro from our collections page at https://everydaymeds.co.uk/collections/wegovy, where all prices include comprehensive clinical assessment and ongoing prescriber support. New customers should apply code FIRST40 at checkout, whilst returning patients use DOSE25 to access our published rates. Our GPhC-registered pharmacy (#9012878) ensures full regulatory compliance throughout your treatment journey, with qualified prescribers available for ongoing medication reviews and dosing adjustments. Treatment success depends on choosing the right medication for your individual circumstances, and our transparent pricing ensures cost never becomes a barrier to accessing either Wegovy or Mounjaro when clinically appropriate. Remember that both medications are prescription-only medicines requiring ongoing medical supervision alongside lifestyle modifications for optimal weight management outcomes.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
